Jeff Yass’s Treace Medical Concepts TMCI Stock Holding History

Jeff Yass’s Portfolio TMCI Stock Details TMCI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-47,900	Closed	-$117K	–	14115
2025 Q4	$117K	Buy	+47,900	New	+$208K	﹤0.01%	11361
2024 Q4	–	Sell	-127,400	Closed	-$739K	–	13222
2024 Q3	$739K	Sell	127,400 -7,600	-6%	-$48.8K	﹤0.01%	7528
2024 Q2	$898K	Buy	135,000 +112,000	+487%	+$905K	﹤0.01%	6848
2024 Q1	$300K	Sell	23,000 -9,300	-29%	-$124K	﹤0.01%	9688
2023 Q4	$412K	Buy	32,300 +6,800	+27%	+$68.7K	﹤0.01%	9118
2023 Q3	$334K	Buy	+25,500	New	+$467K	﹤0.01%	9121
2023 Q2	–	Sell	-18,700	Closed	-$471K	–	13138
2023 Q1	$471K	Buy	+18,700	New	+$439K	﹤0.01%	8705
2022 Q2	–	Sell	-12,700	Closed	-$240K	–	13941
2022 Q1	$240K	Buy	12,700 +400	+3%	+$7.78K	﹤0.01%	10804
2021 Q4	$229K	Buy	+12,300	New	+$254K	﹤0.01%	11156

Other funds holding TMCI

Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Gagnon Securities New York $519M AUM 44.91% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Gagnon Advisors New York $157M AUM 36.77% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

CBU

CIBC Bancorp USA Chicago, Illinois $82.3B AUM

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Jeff Yass's TMCI Position: Q2 2026 in Review

Jeff Yass increased its Treace Medical Concepts (TMCI) stake by 1,156% in Q2 2026, buying an estimated $542K and bringing the position to 214,219 shares worth $853K. The position accounts for ﹤0.01% of the portfolio, ranked #8605.

Jeff Yass first reported a position in TMCI in Q2 2022 and has held it in 15 quarters since. The position peaked at $1.13M in Q1 2023. 117 funds tracked by Wall St. Rank hold TMCI as of Q2 2026.

Jeff Yass held 214,219 shares of Treace Medical Concepts worth $853K as of Q2 2026.
Jeff Yass bought 197,170 Treace Medical Concepts shares in Q2 2026, an estimated $542K.
Treace Medical Concepts made up ﹤0.01% of Jeff Yass's portfolio in Q2 2026, its #8605 holding.
Jeff Yass first reported a position in Treace Medical Concepts in Q2 2022 and has held it in 15 quarters since.
Jeff Yass's Treace Medical Concepts position peaked at $1.13M in Q1 2023.
117 funds tracked by Wall St. Rank held Treace Medical Concepts as of Q2 2026.

Based on Susquehanna International Group's 13F filing for Q2 2026, filed 14 Aug 2026.